Noinart, J., Buttachon, S., Dethoup, T., Gales, L., et al. (2017). A new ergosterol analog, a new bis-anthraquinone and anti-obesity activity of anthraquinones from the marine sponge-associated fungus Talaromyces stipitatus KUFA 0207. Marine Drugs, 15(5).

Freitas, S., Martins, R., Costa, M., Leão, P. N., et al. (2016). Hierridin B Isolated from a Marine Cyanobacterium Alters VDAC1, Mitochondrial Activity, and Cell Cycle Genes on HT-29 Colon Adenocarcinoma Cells. Marine Drugs, 14(9).

Freitas, S., Martins, R., Campos, A., Azevedo, J., et al. (2016). Insights into the potential of picoplanktonic marine cyanobacteria strains for cancer therapies - Cytotoxic mechanisms against the RKO colon cancer cell line. Toxicon, 119, 140 - 151.

Brito, Â., Ramos, V., Seabra, R., Santos, A., et al. (2012). Culture-dependent characterization of cyanobacterial diversity in the intertidal zones of the Portuguese coast: A polyphasic study. Systematic and Applied Microbiology, 35(2), 110 - 119.

Costa, M., Costa-Rodrigues, J., Fernandes, M. H., Barros, P., et al. (2012). Marine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis. Marine Drugs, 10(10), 2181 - 2207.

Lopes, V. R., Schmidtke, M., Helena Fernandes, M., Martins, R., & Vasconcelos, V. (2011). Cytotoxicity in L929 fibroblasts and inhibition of herpes simplex virus type 1 Kupka by estuarine cyanobacteria extracts. Toxicology in Vitro, 25(4), 944 - 950.

Frazão, B., Martins, R., & Vasconcelos, V. (2010). Are known cyanotoxins involved in the toxicity of picoplanktonic and filamentous north atlantic marine cyanobacteria?. Marine Drugs, 8(6), 1908 - 1919.

Lopes, V. R., Fernández, N., Martins, R. F., & Vasconcelos, V. (2010). Primary screening of the bioactivity of brackishwater cyanobacteria: Toxicity of crude extracts to Artemia salina larvae and Paracentrotus lividus embryos. Marine Drugs, 8(3), 471 - 482.